This company develops an automated bioprocessing platform that uses AI and data analysis to accelerate the development and manufacturing of biological products. By streamlining bioprocesses, the platform enables faster, cheaper, and higher-quality production for its customers.
Funding
$201.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Founders
Product
Problem
Cell and gene therapies hold immense promise, but their high manufacturing costs hinder widespread adoption and limit patient access. Traditional bioprocessing methods often involve lengthy wet lab experiments and manual data analysis, leading to inefficiencies and delays in product release.
Solution
Native Labs offers an AI-powered bioprocess operating system that accelerates and optimizes the development and manufacturing of cell and gene therapies. The platform leverages proprietary datasets and state-of-the-art neural networks to predict optimal bioprocess protocols, control bioreactor parameters with precision, and enable real-time quality verification. By eliminating the need for extensive lab experiments and automating data analysis, Native Labs reduces manufacturing costs, accelerates product release, and improves product quality. The system integrates seamlessly with existing workflows, requiring minimal onboarding and no specialized training.
Target Audience
Native Labs primarily targets cell and gene therapy developers and manufacturers seeking to industrialize and future-proof their manufacturing processes.
Features
- Process Prediction Engine: Predicts GMP-ready, scalable process protocols using product information, cell line candidates, and endpoint data.
- Real-Time QC Release and Root Cause Analysis: Predicts key quality metrics using online and offline data inputs, enabling early batch deviation detection and rapid root cause analysis.
- AI-driven parameter optimization for precise bioreactor control.
- Automated report generation for design of experiment data and techno-economic analysis.
- Exploratory data analysis services for multi-omics, spent media analysis, and time-series bioreactor data.
- Bespoke process modeling tailored to specific processes.
- Wet-lab data generation and process validation capabilities.